PATENT CLAIM ANALYSIS

Application Number: 15780134
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Claim (Index 4):
The compound of  claim 1  wherein R 1  is phenyl, which optionally is substituted with two or three substituents independently selected from the group consisting of chloro and tetrazolyl; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15771538', '15116576', '15329609', '15312839', '15329634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8319558990000661
- 35 USC 102 Novelty (BERT): 0.5737119244174336
- Combined Prediction Score: 0.8061315015418028
- Mean Citation Score: 442.1717540000001
- Max Citation Score: 450.88834
- Similarity Product: 421.4271693754149

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test